tiprankstipranks
Celularity (CELU)
NASDAQ:CELU
US Market

Celularity (CELU) Financial Statements

203 Followers

Celularity Financial Overview

Celularity's market cap is currently $36.62M. The company's EPS TTM is $; its P/E ratio is -0.59; Celularity is scheduled to report earnings on March 26, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 25Dec 23Dec 22Mar 22Dec 20
Income Statement
Total Revenue$ 54.22M$ 22.77M$ 17.98M$ 21.34M$ 14.28M
Gross Profit$ 39.23M$ 6.75M$ -1.69M$ 11.68M$ 9.35M
Operating Income$ -38.36M$ -192.29M$ -25.60M$ -109.06M$ -151.93M
EBITDA$ -43.71M$ -183.95M$ -138.83M$ -88.11M$ -202.41M
Net Income$ -57.89M$ -196.29M$ 14.19M$ -100.12M$ -208.23M
Balance Sheet
Cash & Short-Term Investments$ 738.00K$ 227.00K$ 13.97M$ 37.24M$ 54.31M
Total Assets$ 132.68M$ 143.89M$ 401.07M$ 414.13M$ 431.01M
Total Debt$ 68.84M$ 65.42M$ 65.59M$ 31.14M$ 30.64M
Net Debt$ 68.10M$ 65.19M$ 51.62M$ -6.10M$ -23.67M
Total Liabilities$ 123.84M$ 102.93M$ 202.16M$ 314.71M$ 412.30M
Stockholders' Equity$ 8.84M$ 40.96M$ 198.90M$ 99.42M$ 18.71M
Cash Flow
Free Cash Flow$ -6.56M$ -42.73M$ -143.11M$ -116.30M$ -91.03M
Operating Cash Flow$ -6.40M$ -38.69M$ -137.88M$ -110.10M$ -63.19M
Investing Cash Flow$ 514.00K$ -4.05M$ -5.24M$ -5.90M$ -12.81M
Financing Cash Flow$ 6.70M$ 24.09M$ 119.84M$ 98.56M$ 102.01M
Currency in USD

Celularity Earnings and Revenue History

Celularity Debt to Assets

Celularity Cash Flow

Celularity Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.